Login
Population (July 2005)
77.5m
GDP (PPP data, 2004)
$316.3 bn
Health expenditure (2004)
Health expenditure as proportion of GDP (2004)
Size of pharmaceutical market (sales, 2004)
Percentage of GDP spent on pharmaceuticals
Percentage of health expenditure spent on medicines (2004)
Pharmaceutical market growth rate (2004)
Local currency
Egyptian Pound (LE)
Summary: Egypt
In partnership with international organisations, Egypt is currently implementing a reform program to modernise its health system. The government will have to raise public health expenditure substantially to finance care at an adequate level, especially in the light of the continuing demographic trends, but the existence of wide budget deficits leave little room for significant increases in healthcare expenditure.
The government is facing mounting pressures over the current drug price freeze, a policy viewed by many companies as unsustainable in the light of the Egyptian pound’s devaluation. Multinationals are calling for an increase in patent protection, as they complain that generics are entering the market before the patent has expired.
Summary of report content
- Summary
- How is the healthcare system structured?
- What size is the pharmaceutical market?
- Are pharmaceuticals taxed?
- How are drug prices set?
- How are prices changed?
- How are drugs reimbursed?
- Is there a payback arrangement?
- Are hospital sales controlled?
- Are OTC prices regulated?
- How are pharmaceutical costs controlled?
- How are generic drugs priced?
- What are wholesale/pharmacy margins?
- Is parallel trade influential?
- What to look out for
- Glossary
- Useful Contacts
Your Basket
Your basket is currently empty.
Search News
News
09/03/2005
PhRMA expresses concern over illegal generic registration
Related Items